MAXCYTE, INC. Quarterly Assets in USD from Q4 2020 to Q3 2024

Taxonomy & unit: us-gaap: USD
Description: Sum of the carrying amounts as of the balance sheet date of all assets that are recognized. Assets are probable future economic benefits obtained or controlled by an entity as a result of past transactions or events.
Summary: Maxcyte, Inc. quarterly Assets history and growth rate from Q4 2020 to Q3 2024.
Maxcyte, Inc. Assets for the quarter ending September 30, 2024 was $249M, a 6.79% decline year-over-year.

Assets, Quarterly (USD)

Assets, YoY Quarterly Growth (%)

Period	Value	YoY Chg	Change %	Date	Report	Filed
Q3 2024	$249M	-$18.1M	-6.79%	Sep 30, 2024	10-Q	2024-11-06
Q2 2024	$251M	-$19.7M	-7.27%	Jun 30, 2024	10-Q	2024-08-06
Q1 2024	$258M	-$23.6M	-8.39%	Mar 31, 2024	10-Q	2024-05-07
Q4 2023	$268M	-$18.4M	-6.41%	Dec 31, 2023	10-Q	2024-11-06
Q3 2023	$267M	-$19.7M	-6.87%	Sep 30, 2023	10-Q	2023-11-08
Q2 2023	$271M	-$18.6M	-6.41%	Jun 30, 2023	10-Q	2023-08-09
Q1 2023	$282M	-$9.41M	-3.23%	Mar 31, 2023	10-Q	2023-05-10
Q4 2022	$287M	+$2.53M	+0.89%	Dec 31, 2022	10-K	2024-03-12
Q3 2022	$286M	+$8.72M	+3.14%	Sep 30, 2022	10-Q	2022-11-09
Q2 2022	$290M	+$197M	+211%	Jun 30, 2022	10-Q	2022-08-10
Q1 2022	$291M			Mar 31, 2022	10-Q	2022-05-09
Q4 2021	$284M	+$232M	+449%	Dec 31, 2021	10-K	2023-03-15
Q3 2021	$278M			Sep 30, 2021	10-Q	2021-11-10
Q2 2021	$93.1M			Jun 30, 2021	10-Q	2021-09-13
Q4 2020	$51.8M			Dec 31, 2020	10-K	2022-03-22

* An asterisk sign (*) next to the value indicates that the value is likely invalid.